// App-Quantinova.ai

214 : Reliability of echocardiography indices for patent ductus arteriosus evaluation among extremely preterm neonates by neonatologist experts in a national network

Researchers

Presenter

  • Dany E. Weisz

Principal Investigators

  • Xiang Y. Ye

  • Bonny Jasani

  • Sagee Nissimov

  • Abbas Hyderi

  • Aimann H. Surak

  • Amuchou Soraisham

  • Andréanne Villeneuve

  • Anie Lapointe

  • Audrey Hebert

  • Deepak Louis

  • Soume Bhattacharya

  • Faith Zhu

  • Gabriel Altit

  • Michael Castaldo

  • Poorva Deshpande

  • Renjini Lalitha

  • Souvik Mitra

  • Yasser Elsayed

  • Nadya Ben Fadel

  • Joseph Ting

  • George Jacob

  • Prakesh Shah

  • Amish Jain

Medical Centers

  • Mount Sinai Hospital, Toronto, ON, Canada

  • University of Ottawa Faculty of Medicine, Ottawa, ON, Canada

  • Dalhousie University & IWK Health, Halifax, NS, Canada

  • Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada

  • BC Women's Hospital, Vancouver, BC, Canada

  • University of Toronto, Toronto, ON, Canada

  • University of Alberta Faculty of Medicine and Dentistry, Edmonton, AB, Canada

  • Sunnybrook Health Science Centre, University of Toronto, Ancaster Hamilton, ON, Canada

  • The Hospital for Sick Children, Toronto, ON, Canada

  • University of Toronto Temerty Faculty of Medicine, Toronto, ON, Canada

  • University of Toronto/ Mount Sinai Hospital, Toronto, ON, Canada

  • McGill University Faculty of Medicine and Health Sciences, Montreal, PQ, Canada

  • CHU Sainte-Justine, Montréal, PQ, Canada

  • University of Alberta, Edmonton, AB, Canada

  • University of Calgary, Calgary, AB, Canada

  • Mount Sinai Hospital, Mississauga, ON, Canada

  • The University of Western Ontario - Schulich School of Medicine & Dentistry, London, ON, Canada

  • Universite Laval, Quebec city, PQ, Canada

  • MiCare research Center, Mount Sinai Hospital, Toronto, ON, Canada, Toronto, ON, Canada

  • AHS, Edmonton, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Patent ductus arteriosus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

  • Observational

  • Prospective

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A